These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 11076656)
1. Expression of calcium-binding protein S100A2 in breast lesions. Liu D; Rudland PS; Sibson DR; Platt-Higgins A; Barraclough R Br J Cancer; 2000 Dec; 83(11):1473-9. PubMed ID: 11076656 [TBL] [Abstract][Full Text] [Related]
2. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis. Feng G; Xu X; Youssef EM; Lotan R Cancer Res; 2001 Nov; 61(21):7999-8004. PubMed ID: 11691825 [TBL] [Abstract][Full Text] [Related]
3. Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer. Rehman I; Cross SS; Catto JW; Leiblich A; Mukherjee A; Azzouzi AR; Leung HY; Hamdy FC Prostate; 2005 Dec; 65(4):322-30. PubMed ID: 16015609 [TBL] [Abstract][Full Text] [Related]
4. [Expression of S100A2 in secondarily radioresistant pancreatic cancer cells and significance thereof]. Wen Q; Zhao YP; Chen G; Zhang FQ; Zhang TP Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2817-20. PubMed ID: 17200013 [TBL] [Abstract][Full Text] [Related]
5. The Ca2+-binding S100A2 protein is differentially expressed in epithelial tissue of glandular or squamous origin. Nagy N; Hoyaux D; Gielen I; Schäfer BW; Pochet R; Heizmann CW; Kiss R; Salmon I; Decaestecker C Histol Histopathol; 2002 Jan; 17(1):123-30. PubMed ID: 11813862 [TBL] [Abstract][Full Text] [Related]
6. S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability. Buckley NE; D'Costa Z; Kaminska M; Mullan PB Cell Death Dis; 2014 Feb; 5(2):e1070. PubMed ID: 24556685 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of the human S100A2 promoter by wild-type p53. Tan M; Heizmann CW; Guan K; Schafer BW; Sun Y FEBS Lett; 1999 Feb; 445(2-3):265-8. PubMed ID: 10094469 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site. Kirschner RD; Sänger K; Müller GA; Engeland K Nucleic Acids Res; 2008 May; 36(9):2969-80. PubMed ID: 18388131 [TBL] [Abstract][Full Text] [Related]
9. Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development. Shimada A; Kano J; Ishiyama T; Okubo C; Iijima T; Morishita Y; Minami Y; Inadome Y; Shu Y; Sugita S; Takeuchi T; Noguchi M Cancer Sci; 2005 Oct; 96(10):668-75. PubMed ID: 16232198 [TBL] [Abstract][Full Text] [Related]
10. Expression Profile of S100A2 and its Clinicopathological Significance in Renal Cell Carcinoma. Sugiyama T; Ozono S; Miyake H Anticancer Res; 2020 Nov; 40(11):6337-6343. PubMed ID: 33109571 [TBL] [Abstract][Full Text] [Related]
11. Localisation by in situ hybridisation of S100A4 (p9Ka) mRNA in primary human breast tumour specimens. Nikitenko LL; Lloyd BH; Rudland PS; Fear S; Barraclough R Int J Cancer; 2000 Apr; 86(2):219-28. PubMed ID: 10738249 [TBL] [Abstract][Full Text] [Related]
12. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. Mueller A; Schäfer BW; Ferrari S; Weibel M; Makek M; Höchli M; Heizmann CW J Biol Chem; 2005 Aug; 280(32):29186-93. PubMed ID: 15941720 [TBL] [Abstract][Full Text] [Related]
13. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis. Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes. Matsubara D; Niki T; Ishikawa S; Goto A; Ohara E; Yokomizo T; Heizmann CW; Aburatani H; Moriyama S; Moriyama H; Nishimura Y; Funata N; Fukayama M Cancer Sci; 2005 Dec; 96(12):844-57. PubMed ID: 16367903 [TBL] [Abstract][Full Text] [Related]
15. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Liu D; Rudland PS; Sibson DR; Platt-Higgins A; Barraclough R Cancer Res; 2005 May; 65(9):3796-805. PubMed ID: 15867376 [TBL] [Abstract][Full Text] [Related]
16. Frequent polymorphic variations but rare tumour specific mutations of the S100A2 on 1q21 in non-small cell lung cancer. Strazisar M; Rott T; Glavac D Lung Cancer; 2009 Mar; 63(3):354-9. PubMed ID: 18656279 [TBL] [Abstract][Full Text] [Related]
17. S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration. Nagy N; Brenner C; Markadieu N; Chaboteaux C; Camby I; Schäfer BW; Pochet R; Heizmann CW; Salmon I; Kiss R; Decaestecker C Lab Invest; 2001 Apr; 81(4):599-612. PubMed ID: 11304580 [TBL] [Abstract][Full Text] [Related]
18. Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Bártek J; Bártková J; Vojtĕsek B; Stasková Z; Rejthar A; Kovarík J; Lane DP Int J Cancer; 1990 Nov; 46(5):839-44. PubMed ID: 2228312 [TBL] [Abstract][Full Text] [Related]
19. Regulation of S100A2 expression by TGF-β-induced MEK/ERK signalling and its role in cell migration/invasion. Naz S; Ranganathan P; Bodapati P; Shastry AH; Mishra LN; Kondaiah P Biochem J; 2012 Oct; 447(1):81-91. PubMed ID: 22747445 [TBL] [Abstract][Full Text] [Related]
20. Purification and crystallization of the human EF-hand tumour suppressor protein S100A2. Koch M; Diez J; Fritz G Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Nov; 62(Pt 11):1120-3. PubMed ID: 17077493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]